Note: no sound] Traffic flows past the Sutong Bridge in Changshu city, East China's Jiangsu province, Jan 23, 2025. With the arrival of the Spring Festival, expressways around the country ushered in the peak of Spring Festival travel traffic,

The Japanese Foreign Ministry says a Chinese court has handed down a death sentence for a man charged over a knife attack on a bus carrying Japanese schoolchildren.

China’s vast exports in 2024 exceeded its imports on a scale seldom seen anywhere except during or immediately after the two world wars.

Data shows that during last year's Spring Festival rush, travel among those aged 60 and above surged by nearly 30 percent year on year, with more seniors departing from provinces such as Sichuan, Hebei and Hubei to join family members in major cities like Beijing, Shanghai, Guangzhou and Shenzhen.

Chinese officials and ordinary people are hopeful but on edge as Donald Trump returns to the White House, eager to avoid a repeat of the bruising trade war that drove a wedge between the economic superpowers during his first term.

A Chinese court deemed the death penalty as appropriate in view of the 'extremely heinous' nature of the crime, which resulted in the death of a bus attendant.

On January 10, 2025, in Suzhou, located in eastern China’s Jiangsu Province, a video captured a peculiar and amusing moment during a motorcycle ride. A woman noticed a small bee crawling on her motorcycle’s rearview mirror,

The trial of the alleged killer of a boy enrolled in a Japanese school in Shenzhen, China began in the city on Friday, Japan's Ministry of Foreign Affairs said.

A Chinese man who attacked a Japanese mother and child with a knife and killed a Chinese woman who tried to protect them has been sentenced to death, according to the Japanese government.

The Suzhou Intermediate People's Court said the Chinese man named Zhou Jia Sheng, 52, accused of stabbing the three at a Japanese school bus stop in Suzhou, Jiangsu Province, on June 24, was "debt-ridden" and did not want to continue living, a government official told reporters in Tokyo.

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors and executives interviewed by BioPharma Dive.